PHR8952

米氮平

certified reference material, pharmaceutical secondary standard

• 同義詞: Mirtazapine, 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
• 經驗公式（希爾表示法）: C₁₇H₁₉N₃
• CAS號碼: 85650-52-8
• 分子量：: 265.35
• MDL號碼: MFCD00865427
• 分類程式碼代碼: 41116107

屬性

• 等級: certified reference material; pharmaceutical secondary standard
• agency: traceable to Ph. Eur. Y0000705; traceable to USP 1444279
• API 家族: mirtazapine
• CofA: current certificate can be downloaded
• 包裝: pkg of 500 mg
• 應用: pharmaceutical
• 儲存溫度: -10 to -25°C
• SMILES 字串: CN1CCN2C(C1)c3ccccc3Cc4cccnc24
• InChI: 1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3
• InChI 密鑰: RONZAEMNMFQXRA-UHFFFAOYSA-N

描述

一般說明

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

生化／生理作用

Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA). Mirtazapine agonizes selective adrenergic and serotonergic receptors so that both NE release and 5-HT_1A mediated serotonergic signaling are increased.

分析報告

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他說明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

安全資訊

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H302,H336
• 防範說明: P261 - P264 - P270 - P271 - P301 + P312 - P304 + P340 + P312
• 危險分類: Acute Tox. 4 Oral - STOT SE 3
• 標靶器官: Central nervous system
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable